Utility of pancreatic tumor scrapings for organoid development and precision medicine strategies
Fuente:
Wiley Open Access
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2026
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1867021717460746240 |
|---|---|
| author | Caitlin F Tsang Hardik Patel Fatim M Kouassi Binny Khandakar Luce G St. Surin James A Rouse Raditya Utama Deepthi Budagavi Julien T Hohenleitner Adeline Chunton Zhen Zhao Sharon S Fox Cristina C Valente Matthew J Weiss Arvind Rishi Daniel A King James M Crawford Amber N Habowski David A Tuveson |
| author_facet | Caitlin F Tsang Hardik Patel Fatim M Kouassi Binny Khandakar Luce G St. Surin James A Rouse Raditya Utama Deepthi Budagavi Julien T Hohenleitner Adeline Chunton Zhen Zhao Sharon S Fox Cristina C Valente Matthew J Weiss Arvind Rishi Daniel A King James M Crawford Amber N Habowski David A Tuveson Caitlin F Tsang Hardik Patel Fatim M Kouassi Binny Khandakar Luce G St. Surin James A Rouse Raditya Utama Deepthi Budagavi Julien T Hohenleitner Adeline Chunton Zhen Zhao Sharon S Fox Cristina C Valente Matthew J Weiss Arvind Rishi Daniel A King James M Crawford Amber N Habowski David A Tuveson |
| collection | Wiley Open Access |
| contents | Utility of pancreatic tumor scrapings for organoid development and precision medicine strategies Caitlin F Tsang Hardik Patel Fatim M Kouassi Binny Khandakar Luce G St. Surin James A Rouse Raditya Utama Deepthi Budagavi Julien T Hohenleitner Adeline Chunton Zhen Zhao Sharon S Fox Cristina C Valente Matthew J Weiss Arvind Rishi Daniel A King James M Crawford Amber N Habowski David A Tuveson The Journal of Pathology Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers due to late diagnosis and chemoresistance. Patient‐derived organoids (PDOs) hold promise for predicting individualized drug responses, but their establishment is often constrained by the limited availability of tumor material and prior neoadjuvant treatment. Standard PDO generation relies on dissected tissue slices from the cut surface of the tumor, which may include both the invasive front, where it is postulated that more aggressive cancer cells reside, and potentially fewer viable neoplastic cells in the tumor center. This study investigated whether scraping the cut surface of the PDAC enhanced PDO establishment compared to standard tissue samples, to take advantage of potential harvesting of viable neoplastic cells from the invasive front. Tumor scrapings from 26 patients and matched tissue slices from 20 patients were collected. PDOs were successfully established from 10 tumor scrapings and eight matched tissue slices, including three neoadjuvant‐treated cases. Organoid histological architecture was comparable to the surgical tumor specimens, with paired scraping PDOs and tissue slice PDOs showing genomic and transcriptomic concordance. Pharmacotyping demonstrated that scraping PDOs reliably captured patient‐specific chemosensitivity, highlighting the potential for a viable alternative method to standard tissue‐slice PDOs. As proliferative and treatment‐resistant neoplastic cells often originate from tumor edges, increasing representation of the periphery and across the tumor may offer a more clinically relevant model of PDAC biology, improving therapeutic decision‐making and patient outcomes. © 2026 The Pathological Society of Great Britain and Ireland. 10.1002/path.70025 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1002/path.70025 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_path_70025 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2026 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Utility of pancreatic tumor scrapings for organoid development and precision medicine strategies Caitlin F Tsang Hardik Patel Fatim M Kouassi Binny Khandakar Luce G St. Surin James A Rouse Raditya Utama Deepthi Budagavi Julien T Hohenleitner Adeline Chunton Zhen Zhao Sharon S Fox Cristina C Valente Matthew J Weiss Arvind Rishi Daniel A King James M Crawford Amber N Habowski David A Tuveson The Journal of Pathology Utility of pancreatic tumor scrapings for organoid development and precision medicine strategies Caitlin F Tsang Hardik Patel Fatim M Kouassi Binny Khandakar Luce G St. Surin James A Rouse Raditya Utama Deepthi Budagavi Julien T Hohenleitner Adeline Chunton Zhen Zhao Sharon S Fox Cristina C Valente Matthew J Weiss Arvind Rishi Daniel A King James M Crawford Amber N Habowski David A Tuveson The Journal of Pathology Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers due to late diagnosis and chemoresistance. Patient‐derived organoids (PDOs) hold promise for predicting individualized drug responses, but their establishment is often constrained by the limited availability of tumor material and prior neoadjuvant treatment. Standard PDO generation relies on dissected tissue slices from the cut surface of the tumor, which may include both the invasive front, where it is postulated that more aggressive cancer cells reside, and potentially fewer viable neoplastic cells in the tumor center. This study investigated whether scraping the cut surface of the PDAC enhanced PDO establishment compared to standard tissue samples, to take advantage of potential harvesting of viable neoplastic cells from the invasive front. Tumor scrapings from 26 patients and matched tissue slices from 20 patients were collected. PDOs were successfully established from 10 tumor scrapings and eight matched tissue slices, including three neoadjuvant‐treated cases. Organoid histological architecture was comparable to the surgical tumor specimens, with paired scraping PDOs and tissue slice PDOs showing genomic and transcriptomic concordance. Pharmacotyping demonstrated that scraping PDOs reliably captured patient‐specific chemosensitivity, highlighting the potential for a viable alternative method to standard tissue‐slice PDOs. As proliferative and treatment‐resistant neoplastic cells often originate from tumor edges, increasing representation of the periphery and across the tumor may offer a more clinically relevant model of PDAC biology, improving therapeutic decision‐making and patient outcomes. © 2026 The Pathological Society of Great Britain and Ireland. 10.1002/path.70025 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | Utility of pancreatic tumor scrapings for organoid development and precision medicine strategies |
| topic | The Journal of Pathology |
| url | https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.70025 |